+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Paroxetine"

From
Antidepressants Market Report 2025 - Product Thumbnail Image

Antidepressants Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Post-Traumatic Stress Disorder Therapeutics Market Report 2025 - Product Thumbnail Image

Post-Traumatic Stress Disorder Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
Post-traumatic Stress Disorder (PTSD) - Pipeline Insight, 2024 - Product Thumbnail Image

Post-traumatic Stress Disorder (PTSD) - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 80 Pages
  • Global
From
US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026 - Product Thumbnail Image

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026

  • Report
  • February 2021
  • 420 Pages
  • United States
From
From
From
From
Loading Indicator

Paroxetine is a selective serotonin reuptake inhibitor (SSRI) used to treat mental disorders such as depression, anxiety, obsessive-compulsive disorder, and post-traumatic stress disorder. It is one of the most commonly prescribed drugs for these conditions, and is available in both generic and brand-name formulations. Paroxetine is also used to treat premenstrual dysphoric disorder and panic disorder. It is generally well-tolerated, with few side effects, and is available in a variety of dosage forms, including tablets, capsules, and oral suspensions. The paroxetine market is highly competitive, with a number of major pharmaceutical companies offering products. These include Pfizer, GlaxoSmithKline, Eli Lilly, and AstraZeneca. Other companies, such as Mylan, Teva, and Sandoz, also offer generic versions of the drug. Show Less Read more